Skip to main content

Leukemia Research

  • ISSN: 0145-2126

Editor-In-Chief: Ross

Next planned ship date: June 10, 2024

  • 5 Year impact factor: 2.5
  • Impact factor: 2.7

Official journal of the Myelodysplastic Syndromes Foundation. Leukemia Research is an international journal which brings comprehensive and current information to all health care p… Read more

Subscription options

Next planned ship date:
June 10, 2024

Institutional subscription on ScienceDirect

Request a sales quote
Official journal of the Myelodysplastic Syndromes Foundation.

Leukemia Research is an international journal which brings comprehensive and current information to all health care professionals involved in basic and applied clinical research in hematological malignancies. The editors encourage the submission of articles relevant to hematological malignancies. The Journal scope includes reporting studies of cellular and molecular biology, genetics, immunology, epidemiology, clinical evaluation, and therapy of these diseases.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.

Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

You are also welcome to submit to Leukemia Research's open access companion title, Leukemia Research Reports.